Michel F
Clinique Urologique, Hôpital Tenon, Paris.
Ann Urol (Paris). 1988;22(3):161-7.
Renal allograft rejection, in an immunocompetent subject, résults from a cellular and humoral interaction. Lymphokines, which are immunity mediators (particularly interleukin 1 and 2, and gamma interferon) modulate these different cellular populations, among which T lymphocytes play a major role. The current knowledge of rejection mechanisms allows us to evaluate the principal targets of immunosuppressive drugs used to treat allograft rejection.
在免疫功能正常的个体中,同种异体肾移植排斥反应是由细胞和体液相互作用引起的。淋巴因子作为免疫介质(特别是白细胞介素1和2以及γ干扰素)调节这些不同的细胞群体,其中T淋巴细胞起主要作用。目前对排斥反应机制的了解使我们能够评估用于治疗移植排斥反应的免疫抑制药物的主要靶点。